Article Text
Leading article
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
Statistics from Altmetric.com
Footnotes
Correction notice This paper has been modified since it was first published online. All references from 57 onwards have been corrected.
Competing interests LB declares paid participation to advisory boards or educational activities for Abbott, Ferring Pharmaceuticals and MSD.
Provenance and peer review Commissioned; externally peer reviewed.